The provider is based in a third country and wants to enter the EU market.
Ваша обязательная контактная точка в ЕС по статье 22 Акта об ИИ
If you provide a high-risk AI system and you are based outside the EU, the AI Act requires you to appoint an authorised representative established in the Union by written mandate before your system reaches the EU market. We act as that representative.
Established in the EU · one mandate covers all 27 Member States · a single, accountable point of contact for authorities
The provider is based in a third country and wants to enter the EU market.
The system is listed in Annex III or embedded in a product covered by Annex I.
The AI system is placed on the market or put into service in the Union.
Не уверены your system is high-risk? Run the free eligibility check →
General-purpose AI model providers may have a separate, parallel authorised representative obligation under Article 54. This page focuses on Article 22 for high-risk AI systems.
A third-country provider must, by written mandate, appoint a representative established in the EU before placing a high-risk system on the market. The representative becomes the accountable EU contact that authorities can address directly on compliance matters.
For non-EU providers of high-risk AI systems, appointing an Article 22 representative is not optional. It is part of the legal market-access route. Without it, the provider creates avoidable enforcement, buyer, importer and distributor risk.
For provider-obligation breaches, AI Act penalties may reach up to EUR 15 million or 3% of worldwide annual turnover, whichever is higher. Exact exposure depends on the violation type and enforcement context.
| Provider's responsibility | Our responsibility as your AR |
|---|---|
| Design and develop the system. | Hold the mandate and a copy of the documentation in the EU. |
| Draw up the technical documentation. | Keep records available to authorities for 10 years. |
| Carry out the conformity assessment. | Liaise with EU market surveillance authorities. |
| Draw up the EU declaration of conformity. | Respond to authority requests to demonstrate conformity. |
| Affix CE marking where applicable. | Support registration in the EU database where applicable. |
| Remain responsible for compliance. | Be the addressable EU point of contact. |
We step in as your accountable EU contact. We do not take over your engineering or your provider compliance responsibility.
Confirm whether your provider status, EU route and AI system are in scope.
Sign a written mandate defining the Article 22 tasks and boundaries.
Transfer copies of the declaration of conformity, technical documentation and certificates where applicable; we set up the contact channel.
We act as your EU point of contact and hold your records for the statutory period.
Whether you build in the US, the UK, China or anywhere outside the Union, once your high-risk system reaches the EU market you need a representative inside it. Post-Brexit, a UK entity cannot serve as the EU representative for the Union market.
Article 22 representative support for US providers selling or deploying high-risk AI into the EU.
UK providers are third-country providers for EU AI Act purposes and should check Article 22 early.
EU market access for high-risk AI needs a clear representative and documentation workflow.
A genuine, mandateable Union presence for authorities, buyers and market actors.
One team already acting across EU regulatory representative roles in medical devices, REACH and cosmetics.
A single accountable route for all 27 Member States.
We hold your records and face the authorities; we do not overreach into your engineering.
Third-country providers of high-risk AI systems need one before placing the system on the EU market. General-purpose AI model providers may have a parallel duty under Article 54.
No. Article 22 focuses on providers of high-risk AI systems, not every AI tool.
For Annex III high-risk systems, Regulation (EU) 2026/1744 sets 2 December 2027 for Chapter III Sections 1, 2 and 3. Appointment and documentation workflows should still be prepared early.
Article 22 record-keeping runs for 10 years after the high-risk AI system has been placed on the market or put into service.
Potentially, yes, if the mandate, documentation availability and operational workflow are clear for each system.
The representative must terminate the mandate and immediately inform the relevant market surveillance authority, and the notified body where applicable, stating the reasons.
Confirm your obligations in minutes and secure your EU point of contact: one mandate for the whole Union market.